Abstract Details

Title T-Effective, T-Regulatory and B-Cells in Newly Natalizumab-Treated MS Patients: Implications for Recognition of Early Response to Therapy

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 221

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Athanasia Alexoudi, MD	Dr. Alexoudi has nothing to disclose.
Anne Nguyen	No disclosure on file
Styliani (. Marousi	No disclosure on file
	No disclosure on file
Themistokles Kalamatas (General Anthens Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
Clementine Karageorgiou, MD (Neurological Institute of Athens)	The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.

��ɫ��